Drugs / ALPS12
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07107490 | Oct 2025 → Sep 2028 expected | small cell lung carcinoma | Chugai Pharmaceutical | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALPS12 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07107490 ↗ |
| Route | Intravenous | “ALPS12 as an IV infusion” NCT07107490 ↗ |